INTRAOCULAR LYMPHOMA

Clinical trials for INTRAOCULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INTRAOCULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for INTRAOCULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 3 Completed 1

New hope for aggressive lymphoma: drug combo shows promise in early trial

Disease control Completed

This study tested a combination of the drug lenalidomide with standard chemotherapy (called DA-EPOCH-R) in 55 people with a fast-growing type of B-cell lymphoma linked to the MYC gene. The goal was to find the safest dose and see if the combo helps keep the cancer from growing or…

Matched conditions: INTRAOCULAR LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control

Last updated May 17, 2026 08:50 UTC

INTRAOCULAR LYMPHOMA

Get alerted when new INTRAOCULAR LYMPHOMA trials appear

New hope for aggressive lymphoma: drug combo shows promise in early trial